Cargando…
2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
BACKGROUND: Understanding the transmissibility of respiratory viruses by symptoms is important for public health. METHODS: Persons who tested positive for SARS-CoV-2 and their household contacts (HHC) were recruited from 7 US sentinel sites or by remote invitation nationwide during Sep. 2021—Mar. 20...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678927/ http://dx.doi.org/10.1093/ofid/ofad500.1924 |
_version_ | 1785150472547467264 |
---|---|
author | Mellis, Alexandra Smith-Jeffcoat, Sarah E Petrie, Joshua Keipp Talbot, H Morrissey, Kerry Grace Stockwell, Melissa Maldonado, Yvonne A Bowman, Natalie M Lutrick, Karen Rao, Suchitra Salvatore, Phillip P Biddle, Jessica E Olivo, Vanessa Battan-Wraith, Steph Merrill, Lori S McLaren, Son H Sano, Ellen Diaz, Anny Sarnquist, Clea Govindaranjan, Prasanthi Goodman, Sara H Ellingson, Katherine Ledezma, Karla I Pryor, Kathleen Lin, Jessica T Bullock, Ayla Yang, Amy Belongia, Edward McLean, Huong Asturias, Edwin J Izurieta, Hector Hart, Kimberly W Schmitz, Jonathan Zhu, Yuwei Rolfes, Melissa A Grijalva, Carlos G |
author_facet | Mellis, Alexandra Smith-Jeffcoat, Sarah E Petrie, Joshua Keipp Talbot, H Morrissey, Kerry Grace Stockwell, Melissa Maldonado, Yvonne A Bowman, Natalie M Lutrick, Karen Rao, Suchitra Salvatore, Phillip P Biddle, Jessica E Olivo, Vanessa Battan-Wraith, Steph Merrill, Lori S McLaren, Son H Sano, Ellen Diaz, Anny Sarnquist, Clea Govindaranjan, Prasanthi Goodman, Sara H Ellingson, Katherine Ledezma, Karla I Pryor, Kathleen Lin, Jessica T Bullock, Ayla Yang, Amy Belongia, Edward McLean, Huong Asturias, Edwin J Izurieta, Hector Hart, Kimberly W Schmitz, Jonathan Zhu, Yuwei Rolfes, Melissa A Grijalva, Carlos G |
author_sort | Mellis, Alexandra |
collection | PubMed |
description | BACKGROUND: Understanding the transmissibility of respiratory viruses by symptoms is important for public health. METHODS: Persons who tested positive for SARS-CoV-2 and their household contacts (HHC) were recruited from 7 US sentinel sites or by remote invitation nationwide during Sep. 2021—Mar. 2023. The household primary case was the person with the earliest symptom onset or positive test. Starting ≤6 days after primary case onset, primary cases and HHC completed symptom logs (daily, retrospective since onset and for 10 days post-enrollment) and collected nasal or saliva specimens (daily for 10 days) that were tested by RT-PCR. Infected individuals were counted as having developed fever, lower respiratory symptoms (LRS: wheezing, chest tightness/pain, shortness of breath, cough), other symptoms (fatigue, aches, abdominal pain, diarrhea, vomiting, change of taste/smell, headache, sore throat, runny nose, nasal congestion), or as being asymptomatic based on all logs. Risk of secondary infection (any PCR positivity) among eligible, tested HHC (Methods 1) by symptoms of primary cases was estimated using Poisson regression with generalized estimating equations. We estimated days from onset to last PCR positive in a survival model. Methods upload 1. Enrolled and analytically included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sept 2021 - Mar 2023. [Figure: see text] RESULTS: This analysis included 842 households (839 primary cases, 836 infected HHC, and 615 uninfected HHC, median household size of 2). Most primary cases (99%) and infected HHC (81%) were symptomatic (Results 1). Primary cases had higher frequencies of fever or LRS than infected HHC (Results 2). HHC exposed to primary cases who developed fever or LRS were more likely to become infected than HHC exposed to primary cases who did not have fever or LRS (Results 3). Post-hoc comparisons by individual symptoms supported this for fever and all LRS but chest pain (fever: IRR 1.31 95% CI: 1.13-1.52; cough: IRR 1.54 95% CI 1.21 – 1.95; wheezing: IRR 1.20 95% CI 1.08 – 1.35; shortness of breath IRR 1.15, 95% CI 1.04 – 1.27). Primary cases with fever or LRS were PCR positive for a median of 14 days (95% CI: 14 – 15) post-onset, compared to 10 days (95% CI: 9 – 11) for cases who did not have fever or LRS. Results upload 1. Characteristics of included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sep 2021 - Mar 2023. [Figure: see text] Results upload 2. Proportion of primary cases and infected household contacts who experienced individual symptoms. [Figure: see text] Results upload 3. Unadjusted and adjusted risk of household contacts becoming infected with SARS-CoV-2, by symptoms in the primary case. [Figure: see text] CONCLUSION: Contacts of primary cases with fever or lower respiratory symptoms may have been more likely to become infected than contacts of primary cases without, suggesting higher transmissibility. DISCLOSURES: Joshua Petrie, PhD, CSL Seqirus: Grant/Research Support Yvonne A. Maldonado, MD, Pfizer: Grant/Research Support|Pfizer: Site Investigator, DSMB member Suchitra Rao, MBBS, MSCS, Sequiris: Advisor/Consultant Edward Belongia, MD, Seqirus: Grant/Research Support Huong McLean, PhD, MPH, Seqirus: Grant/Research Support Edwin J. Asturias, MD, Hillevax: Advisor/Consultant|Moderna: Advisor/Consultant|Pfizer: Grant/Research Support Carlos G. Grijalva, MD, MPH, AHRQ: Grant/Research Support|CDC: Grant/Research Support|FDA: Grant/Research Support|Merck: Advisor/Consultant|NIH: Grant/Research Support|Syneos Health: Grant/Research Support |
format | Online Article Text |
id | pubmed-10678927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106789272023-11-27 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study Mellis, Alexandra Smith-Jeffcoat, Sarah E Petrie, Joshua Keipp Talbot, H Morrissey, Kerry Grace Stockwell, Melissa Maldonado, Yvonne A Bowman, Natalie M Lutrick, Karen Rao, Suchitra Salvatore, Phillip P Biddle, Jessica E Olivo, Vanessa Battan-Wraith, Steph Merrill, Lori S McLaren, Son H Sano, Ellen Diaz, Anny Sarnquist, Clea Govindaranjan, Prasanthi Goodman, Sara H Ellingson, Katherine Ledezma, Karla I Pryor, Kathleen Lin, Jessica T Bullock, Ayla Yang, Amy Belongia, Edward McLean, Huong Asturias, Edwin J Izurieta, Hector Hart, Kimberly W Schmitz, Jonathan Zhu, Yuwei Rolfes, Melissa A Grijalva, Carlos G Open Forum Infect Dis Abstract BACKGROUND: Understanding the transmissibility of respiratory viruses by symptoms is important for public health. METHODS: Persons who tested positive for SARS-CoV-2 and their household contacts (HHC) were recruited from 7 US sentinel sites or by remote invitation nationwide during Sep. 2021—Mar. 2023. The household primary case was the person with the earliest symptom onset or positive test. Starting ≤6 days after primary case onset, primary cases and HHC completed symptom logs (daily, retrospective since onset and for 10 days post-enrollment) and collected nasal or saliva specimens (daily for 10 days) that were tested by RT-PCR. Infected individuals were counted as having developed fever, lower respiratory symptoms (LRS: wheezing, chest tightness/pain, shortness of breath, cough), other symptoms (fatigue, aches, abdominal pain, diarrhea, vomiting, change of taste/smell, headache, sore throat, runny nose, nasal congestion), or as being asymptomatic based on all logs. Risk of secondary infection (any PCR positivity) among eligible, tested HHC (Methods 1) by symptoms of primary cases was estimated using Poisson regression with generalized estimating equations. We estimated days from onset to last PCR positive in a survival model. Methods upload 1. Enrolled and analytically included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sept 2021 - Mar 2023. [Figure: see text] RESULTS: This analysis included 842 households (839 primary cases, 836 infected HHC, and 615 uninfected HHC, median household size of 2). Most primary cases (99%) and infected HHC (81%) were symptomatic (Results 1). Primary cases had higher frequencies of fever or LRS than infected HHC (Results 2). HHC exposed to primary cases who developed fever or LRS were more likely to become infected than HHC exposed to primary cases who did not have fever or LRS (Results 3). Post-hoc comparisons by individual symptoms supported this for fever and all LRS but chest pain (fever: IRR 1.31 95% CI: 1.13-1.52; cough: IRR 1.54 95% CI 1.21 – 1.95; wheezing: IRR 1.20 95% CI 1.08 – 1.35; shortness of breath IRR 1.15, 95% CI 1.04 – 1.27). Primary cases with fever or LRS were PCR positive for a median of 14 days (95% CI: 14 – 15) post-onset, compared to 10 days (95% CI: 9 – 11) for cases who did not have fever or LRS. Results upload 1. Characteristics of included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sep 2021 - Mar 2023. [Figure: see text] Results upload 2. Proportion of primary cases and infected household contacts who experienced individual symptoms. [Figure: see text] Results upload 3. Unadjusted and adjusted risk of household contacts becoming infected with SARS-CoV-2, by symptoms in the primary case. [Figure: see text] CONCLUSION: Contacts of primary cases with fever or lower respiratory symptoms may have been more likely to become infected than contacts of primary cases without, suggesting higher transmissibility. DISCLOSURES: Joshua Petrie, PhD, CSL Seqirus: Grant/Research Support Yvonne A. Maldonado, MD, Pfizer: Grant/Research Support|Pfizer: Site Investigator, DSMB member Suchitra Rao, MBBS, MSCS, Sequiris: Advisor/Consultant Edward Belongia, MD, Seqirus: Grant/Research Support Huong McLean, PhD, MPH, Seqirus: Grant/Research Support Edwin J. Asturias, MD, Hillevax: Advisor/Consultant|Moderna: Advisor/Consultant|Pfizer: Grant/Research Support Carlos G. Grijalva, MD, MPH, AHRQ: Grant/Research Support|CDC: Grant/Research Support|FDA: Grant/Research Support|Merck: Advisor/Consultant|NIH: Grant/Research Support|Syneos Health: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10678927/ http://dx.doi.org/10.1093/ofid/ofad500.1924 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Mellis, Alexandra Smith-Jeffcoat, Sarah E Petrie, Joshua Keipp Talbot, H Morrissey, Kerry Grace Stockwell, Melissa Maldonado, Yvonne A Bowman, Natalie M Lutrick, Karen Rao, Suchitra Salvatore, Phillip P Biddle, Jessica E Olivo, Vanessa Battan-Wraith, Steph Merrill, Lori S McLaren, Son H Sano, Ellen Diaz, Anny Sarnquist, Clea Govindaranjan, Prasanthi Goodman, Sara H Ellingson, Katherine Ledezma, Karla I Pryor, Kathleen Lin, Jessica T Bullock, Ayla Yang, Amy Belongia, Edward McLean, Huong Asturias, Edwin J Izurieta, Hector Hart, Kimberly W Schmitz, Jonathan Zhu, Yuwei Rolfes, Melissa A Grijalva, Carlos G 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study |
title | 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study |
title_full | 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study |
title_fullStr | 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study |
title_full_unstemmed | 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study |
title_short | 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study |
title_sort | 2302. transmissibility of sars-cov-2 by symptom: data from a case-ascertained household transmission study |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678927/ http://dx.doi.org/10.1093/ofid/ofad500.1924 |
work_keys_str_mv | AT mellisalexandra 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT smithjeffcoatsarahe 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT petriejoshua 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT keipptalboth 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT morrisseykerrygrace 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT stockwellmelissa 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT maldonadoyvonnea 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT bowmannataliem 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT lutrickkaren 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT raosuchitra 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT salvatorephillipp 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT biddlejessicae 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT olivovanessa 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT battanwraithsteph 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT merrillloris 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT mclarensonh 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT sanoellen 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT diazanny 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT sarnquistclea 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT govindaranjanprasanthi 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT goodmansarah 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT ellingsonkatherine 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT ledezmakarlai 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT pryorkathleen 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT linjessicat 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT bullockayla 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT yangamy 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT belongiaedward 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT mcleanhuong 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT asturiasedwinj 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT izurietahector 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT hartkimberlyw 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT schmitzjonathan 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT zhuyuwei 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT rolfesmelissaa 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy AT grijalvacarlosg 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy |